Lonza Group Ag EPS - Earnings per Share 2012-2024 | LZAGY

Lonza Group Ag annual and quarterly earnings per share history from 2012 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Lonza Group Ag EPS for the quarter ending December 31, 2024 was $0.00, a 0% increase year-over-year.
  • Lonza Group Ag EPS for the twelve months ending December 31, 2024 was $0.00, a 0% increase year-over-year.
  • Lonza Group Ag 2024 annual EPS was $1.01, a 2.43% increase from 2023.
  • Lonza Group Ag 2023 annual EPS was $0.99, a 42.23% decline from 2022.
  • Lonza Group Ag 2022 annual EPS was $1.71, a 60.41% decline from 2021.
Lonza Group Ag Annual EPS
2024 $1.01
2023 $0.99
2022 $1.71
2021 $4.32
2020 $1.24
2019 $0.87
2017 $1.09
2016 $0.58
2015 $0.55
2014 $0.50
2013 $0.18
2012 $0.39
2011 $0.00
Lonza Group Ag Quarterly EPS
2024-12-31 $0.00
2024-06-30 $0.00
2023-12-31 $0.00
2023-06-30 $0.00
2022-12-31 $0.00
2022-06-30 $0.00
2021-12-31 $0.00
2021-06-30 $0.00
2020-12-31 $0.00
2020-06-30 $0.00
2019-12-31 $0.00
2019-06-30 $0.00
2018-12-31 $0.00
2018-06-30 $0.00
2017-12-31 $0.00
2017-06-30 $0.00
2016-12-31 $0.00
2016-06-30 $0.00
2015-12-31 $0.00
2015-06-30 $0.00
2014-12-31 $0.00
2014-06-30 $0.00
2013-12-31 $0.00
2013-06-30 $0.00
2012-12-31 $0.00
2012-06-30 $0.00
2011-12-31 $0.00
2011-06-30 $0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $49.554B $7.468B
Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.329B 27.82
Boston Scientific (BSX) United States $151.540B 37.94
Stryker (SYK) United States $146.015B 30.53
EssilorLuxottica (ESLOY) France $127.709B 0.00
Medtronic (MDT) Ireland $109.786B 15.56
Haleon (HLN) United Kingdom $49.214B 28.03
ResMed (RMD) United States $36.648B 27.53
Agilent Technologies (A) United States $32.650B 21.28
GE HealthCare Technologies (GEHC) United States $32.569B 15.46
Terumo (TRUMY) Japan $26.857B 34.88
Insulet (PODD) United States $22.464B 88.18
Koninklijke Philips (PHG) Netherlands $21.600B 15.53
Zimmer Biomet Holdings (ZBH) United States $18.095B 11.62
Baxter (BAX) United States $15.380B 11.48
Smith & Nephew SNATS (SNN) United Kingdom $12.819B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.043B 21.03
Lantheus Holdings (LNTH) United States $5.509B 13.90
Prestige Consumer Healthcare (PBH) United States $4.190B 18.72
Perrigo (PRGO) Ireland $3.610B 9.15
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.346B 15.24
ICU Medical (ICUI) United States $3.233B 23.84
Envista Holdings (NVST) United States $3.178B 26.41
GN Store Nord (GNNDY) Denmark $2.155B 17.85
QuidelOrtho (QDEL) United States $2.102B 14.46
LeMaitre Vascular (LMAT) United States $1.865B 41.69
AtriCure (ATRC) United States $1.729B 0.00
Acuren (TIC) United States $1.228B 0.00
AdaptHealth (AHCO) United States $1.196B 12.14
Green Thumb Industries (GTBIF) United States $1.101B 24.76
Neogen (NEOG) United States $1.077B 13.78
BioLife Solutions (BLFS) United States $1.046B 0.00
Kestra Medical Technologies (KMTS) United States $1.016B 0.00
Phibro Animal Health (PAHC) United States $0.972B 12.42
InMode (INMD) Israel $0.931B 9.38
Evolus (EOLS) United States $0.632B 0.00
CeriBell (CBLL) United States $0.619B 0.00
Curaleaf Holdings (CURLF) Canada $0.571B 0.00
Capricor Therapeutics (CAPR) United States $0.564B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.563B 0.00
Valneva SE (VALN) France $0.523B 0.00
Owens & Minor (OMI) United States $0.515B 4.27
Surmodics (SRDX) United States $0.429B 0.00
Tilray Brands (TLRY) Canada $0.412B 0.00
VAREX IMAGING (VREX) United States $0.340B 12.52
SNDL (SNDL) Canada $0.339B 0.00
Aurora Cannabis (ACB) Canada $0.313B 55.70
SEMPERIT AG HLD (SEIGY) Austria $0.291B 0.00
Cerus (CERS) United States $0.275B 0.00
Viemed Healthcare (VMD) United States $0.272B 22.90
Sanara MedTech (SMTI) United States $0.260B 0.00
ZimVie (ZIMV) United States $0.255B 11.61
Cresco Labs (CRLBF) United States $0.250B 0.00
Canopy Growth (CGC) Canada $0.239B 0.00
Sanuwave Health (SNWV) United States $0.231B 0.00
OraSure Technologies (OSUR) United States $0.217B 0.00
Quanterix (QTRX) United States $0.217B 0.00
Verano Holdings (VRNOF) United States $0.205B 0.00
Brainsway (BWAY) Israel $0.198B 52.30
Omeros (OMER) United States $0.196B 0.00
TriSalus Life Sciences (TLSI) United States $0.195B 0.00
Biote (BTMD) United States $0.194B 5.45
High Tide (HITI) Canada $0.188B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.80
Organigram Global (OGI) Canada $0.179B 0.00
Exagen (XGN) United States $0.157B 0.00
FitLife Brands (FTLF) United States $0.136B 16.72
Vireo Growth (VREOF) United States $0.125B 0.00
Jin Medical (ZJYL) China $0.121B 0.00
Veru (VERU) United States $0.096B 0.00
MacroGenics (MGNX) United States $0.095B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
Quipt Home Medical (QIPT) United States $0.092B 0.00
Fonar (FONR) United States $0.090B 11.56
TerrAscend (TSNDF) Canada $0.089B 0.00
Agape ATP (ATPC) $0.077B 0.00
InterCure (INCR) Israel $0.069B 0.00
Zynex (ZYXI) United States $0.065B 0.00
Apyx Medical (APYX) United States $0.063B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Modular Medical (MODD) United States $0.045B 0.00
United-Guardian (UG) United States $0.038B 13.02
Nephros (NEPH) United States $0.035B 47.43
Rockwell Medical (RMTI) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
Cellectar Biosciences (CLRB) United States $0.021B 0.00
Safety Shot (SHOT) United States $0.020B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00